These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476 [TBL] [Abstract][Full Text] [Related]
4. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788 [TBL] [Abstract][Full Text] [Related]
5. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population. Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. Parad RB; Comeau AM J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789 [TBL] [Abstract][Full Text] [Related]
7. Lessons learned from 20 years of newborn screening for cystic fibrosis. Massie RJ; Curnow L; Glazner J; Armstrong DS; Francis I Med J Aust; 2012 Jan; 196(1):67-70. PubMed ID: 22256939 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of 47,213 infants in neonatal screening for cystic fibrosis, using pancreatitis-associated protein and immunoreactive trypsinogen assays]. Barthellemy S; Maurin N; Roussey M; Férec C; Murolo S; Berthézène P; Iovanna JL; Dagorn JC; Sarles J Arch Pediatr; 2001 Mar; 8(3):275-81. PubMed ID: 11270251 [TBL] [Abstract][Full Text] [Related]
9. Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process. Munck A; Delmas D; Audrézet MP; Lemonnier L; Cheillan D; Roussey M J Med Screen; 2018 Mar; 25(1):6-12. PubMed ID: 28454512 [TBL] [Abstract][Full Text] [Related]
10. Sweat testing following newborn screening for cystic fibrosis. Massie J; Gaskin K; Van Asperen P; Wilcken B Pediatr Pulmonol; 2000 Jun; 29(6):452-6. PubMed ID: 10821727 [TBL] [Abstract][Full Text] [Related]
12. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population. Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923 [TBL] [Abstract][Full Text] [Related]
13. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747 [TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. Hale JE; Parad RB; Dorkin HL; Gerstle R; Lapey A; O'Sullivan BP; Spencer T; Yee W; Comeau AM J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S255-61. PubMed ID: 20521170 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program. Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188 [TBL] [Abstract][Full Text] [Related]
17. Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). Massie RJ; Olsen M; Glazner J; Robertson CF; Francis I Med J Aust; 2000 Jun; 172(12):584-7. PubMed ID: 10914103 [TBL] [Abstract][Full Text] [Related]
18. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening. Keiles S; Koepke R; Parad R; Kharrazi M; J Cyst Fibros; 2012 May; 11(3):257-60. PubMed ID: 22209734 [TBL] [Abstract][Full Text] [Related]
19. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening. Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149 [TBL] [Abstract][Full Text] [Related]
20. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening. Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM; Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]